Ornovi, Inc.
🇺🇸United States
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A First in Human Single and Multiple Ascending Dose and Open Label Food Effect Study of OR-101 in Healthy Subjects
Phase 1
Withdrawn
- Conditions
- Alopecia Areata
- Interventions
- Drug: OR-101 (Single ascending dose)Drug: OR-101 (Food effect)Drug: OR-101 (Multiple ascending dose)Drug: Placebo
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2024-04-05
- Lead Sponsor
- Ornovi, Inc.
- Registration Number
- NCT06045624
- Locations
- 🇦🇺
SCIENTIA Clinical Research Ltd, Randwick, New South Wales, Australia
News
No news found